CLOVER HEALTH INVESTMENTS, CORP. /DE vs ELEVANCE HEALTH, INC., two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CLOV and ELV diverge most: on net margin, CLOV reads -0.7% and ELV reads 2.5%; on return on equity, CLOV reads -4.9% and ELV reads 11.0%. The rest of the comparable metrics sit closer together. What ELV's price implies is a bet that sits within the historical range (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | CLOV | ELV |
|---|---|---|
| Price | $4.83 | $418.65 |
| Market cap | $2.6B | $91.2B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Mature |
| P/E | — | 18.5 |
| P/B | 7.00 | 2.03 |
| P/S | 1.06 | 0.45 |
| EV/EBITDA | 60.9 | 20.6 |
| Revenue growth | +53.1% | +6.5% |
| Operating margin | 3.8% | 3.5% |
| Net margin | -0.7% | 2.5% |
| Return on equity | -4.9% | 11.0% |
| Return on assets | -2.5% | 3.9% |
| Return on invested capital | 8.7% | 5.3% |
| FCF yield | 2.8% | 6.9% |
| Dividend yield | — | 1.4% |
| Debt / equity | 0.00 | 0.70 |
| Current ratio | 1.50 | 1.52 |
| Altman Z (solvency) | 4.09 | 2.93 |
| Piotroski F (quality) | 5 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.